Eagle Capital Growth Fund
6 hedge funds and large institutions have $582K invested in Eagle Capital Growth Fund in 2022 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 6 → 6 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
0.68% less ownership
Funds ownership: 2.22% → 1.53% (-0.68%)
29% less capital invested
Capital invested by funds: $821K → $582K (-$239K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
+$10 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$122K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$58.4K |
| 3 |
CL
CSS LLC
Chicago,
Illinois
|
-$57.1K |
GRF Hedge Fund Activity: Q1 2022 in Review
6 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Eagle Capital Growth Fund (GRF) for Q1 2022, worth a combined $582K — down 29% from $821K a quarter earlier.
Fund positioning in GRF was balanced in Q1 2022: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 2 trimmed.
The largest buyer was Wells Fargo, opening a new position worth an estimated $10. The largest seller was Raymond James & Associates, exiting entirely with an estimated $122K sold.
- 6 institutional investors held Eagle Capital Growth Fund (GRF) as of Q1 2022, unchanged from Q4 2021.
- Funds reported $582K of Eagle Capital Growth Fund stock for Q1 2022, down 29% quarter-over-quarter.
- 1 fund opened new Eagle Capital Growth Fund positions in Q1 2022 and 1 closed out, a net change of 0 holders.
- The largest Eagle Capital Growth Fund buyer in Q1 2022 was Wells Fargo, an estimated $10 added.
- The largest Eagle Capital Growth Fund seller in Q1 2022 was Raymond James & Associates, an estimated $122K sold.
Based on aggregated 13F filings for Q1 2022.